277 related articles for article (PubMed ID: 21929751)
1. Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism.
Sureban SM; May R; Mondalek FG; Qu D; Ponnurangam S; Pantazis P; Anant S; Ramanujam RP; Houchen CW
J Nanobiotechnology; 2011 Sep; 9():40. PubMed ID: 21929751
[TBL] [Abstract][Full Text] [Related]
2. Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanism.
Sureban SM; May R; Ramalingam S; Subramaniam D; Natarajan G; Anant S; Houchen CW
Gastroenterology; 2009 Aug; 137(2):649-59, 659.e1-2. PubMed ID: 19445940
[TBL] [Abstract][Full Text] [Related]
3. DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism.
Sureban SM; May R; Lightfoot SA; Hoskins AB; Lerner M; Brackett DJ; Postier RG; Ramanujam R; Mohammed A; Rao CV; Wyche JH; Anant S; Houchen CW
Cancer Res; 2011 Mar; 71(6):2328-38. PubMed ID: 21285251
[TBL] [Abstract][Full Text] [Related]
4. Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism.
Sureban SM; Madhoun MF; May R; Qu D; Ali N; Fazili J; Weygant N; Chandrakesan P; Ding K; Lightfoot SA; Houchen CW
Oncotarget; 2015 Nov; 6(35):37200-15. PubMed ID: 26468984
[TBL] [Abstract][Full Text] [Related]
5. DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancer.
Sureban SM; May R; Qu D; Weygant N; Chandrakesan P; Ali N; Lightfoot SA; Pantazis P; Rao CV; Postier RG; Houchen CW
PLoS One; 2013; 8(9):e73940. PubMed ID: 24040120
[TBL] [Abstract][Full Text] [Related]
6. XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism.
Sureban SM; May R; Weygant N; Qu D; Chandrakesan P; Bannerman-Menson E; Ali N; Pantazis P; Westphalen CB; Wang TC; Houchen CW
Cancer Lett; 2014 Aug; 351(1):151-61. PubMed ID: 24880079
[TBL] [Abstract][Full Text] [Related]
7. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
[TBL] [Abstract][Full Text] [Related]
8. The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice.
He XY; Chen JX; Zhang Z; Li CL; Peng QL; Peng HM
J Cancer Res Clin Oncol; 2010 Jul; 136(7):1023-8. PubMed ID: 20033209
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.
Sun M; Song H; Wang S; Zhang C; Zheng L; Chen F; Shi D; Chen Y; Yang C; Xiang Z; Liu Q; Wei C; Xiong B
J Hematol Oncol; 2017 Mar; 10(1):79. PubMed ID: 28356122
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
[TBL] [Abstract][Full Text] [Related]
12. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAs.
Shu J; Xia Z; Li L; Liang ET; Slipek N; Shen D; Foo J; Subramanian S; Steer CJ
RNA Biol; 2012 Oct; 9(10):1275-87. PubMed ID: 22995834
[TBL] [Abstract][Full Text] [Related]
14. IFN-γ-mediated IRF1/miR-29b feedback loop suppresses colorectal cancer cell growth and metastasis by repressing IGF1.
Yuan L; Zhou C; Lu Y; Hong M; Zhang Z; Zhang Z; Chang Y; Zhang C; Li X
Cancer Lett; 2015 Apr; 359(1):136-47. PubMed ID: 25592039
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-130b promotes tumor development and is associated with poor prognosis in colorectal cancer.
Colangelo T; Fucci A; Votino C; Sabatino L; Pancione M; Laudanna C; Binaschi M; Bigioni M; Maggi CA; Parente D; Forte N; Colantuoni V
Neoplasia; 2013 Sep; 15(9):1086-99. PubMed ID: 24027433
[TBL] [Abstract][Full Text] [Related]
16. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
17. MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway.
Wang B; Shen ZL; Gao ZD; Zhao G; Wang CY; Yang Y; Zhang JZ; Yan YC; Shen C; Jiang KW; Ye YJ; Wang S
Cell Cycle; 2015; 14(7):1046-58. PubMed ID: 25602366
[TBL] [Abstract][Full Text] [Related]
18. Fentanyl inhibits proliferation and invasion of colorectal cancer via β-catenin.
Zhang XL; Chen ML; Zhou SL
Int J Clin Exp Pathol; 2015; 8(1):227-35. PubMed ID: 25755709
[TBL] [Abstract][Full Text] [Related]
19. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
[TBL] [Abstract][Full Text] [Related]
20. Inhibition effect of exosomes-mediated Let-7a on the development and metastasis of triple negative breast cancer by down-regulating the expression of c-Myc.
Du J; Fan JJ; Dong C; Li HT; Ma BL
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5301-5314. PubMed ID: 31298382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
